MichaelBYangMD
Ophthalmology • Liberty Township, OHPediatric & Strabismus
Professor, Ophthalmology, University of Cincinnati College of Medicine
Dr. Yang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7185 Liberty Centre Dr
Ste D
Liberty Township, OH 45069Phone+1 513-443-2506Fax+1 432-999-9256
Summary
- Dr. Michael Yang is an ophthalmologist in Cincinnati, OH and is affiliated with Cincinnati Children's Hospital Medical Center. He received his medical degree from Harvard Medical School and has been in practice 24 years. He specializes in pediatric & strabismus and is experienced in glaucoma and related disorders, pediatric ophthalmology, strabismus repair, and strabismus, cataract, glaucoma, retinopathy of prematurity, nystagmus.
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 1994 - 1997
St Elizabeth's Medical CenterInternship, Internal Medicine, 1993 - 1994
Harvard Medical SchoolClass of 1993
Certifications & Licensure
CA State Medical License 1995 - 2025
KY State Medical License 2004 - 2025
OH State Medical License 2002 - 2025
IN State Medical License 2021 - 2021
MI State Medical License 1998 - 2002- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Honor Award American Academy of Ophthalmology, 2016
- Honor Award American Association for Pediatric Ophthalmology and Strabismus, 2016
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP Start of enrollment: 2022 Apr 27
Roles: Contact
- Bevacizumab Treatment For Type 1 ROP Start of enrollment: 2022 May 18
Roles: Contact
Publications & Presentations
PubMed
- 9 citationsTreatment of non–type 1 retinopathy of prematurity in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) studyTianyu Liu, Lauren A. Tomlinson, Gui-Shuang Ying, Michael B. Yang, Gil Binenbaum
Journal of AAPOS. 2019-10-26 - 5 citationsOcular and developmental outcomes of a dosing study of bevacizumab for retinopathy of prematurity.David K Wallace, Amra Hercinovic, Sharon F Freedman, Eric R Crouch, Amit R Bhatt
Journal of AAPOS. 2023-02-01 - 12 citationsLow- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes.Sharon F Freedman, Amra Hercinovic, David K Wallace, Raymond T Kraker, Zhuokai Li
Ophthalmology. 2022-10-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
